Form 4 for MNKD MANNKIND CORP
Accepted 2025-02-13 00:00:00 ET · period of report 2025-02-12 · accession 0000950170-25-020295 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-13 | 2025-02-12 | MNKD | Marasco Dominic | Pres, Endocrine Business Unit | A - Grant | $0.00 | +252.0K | 252.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 Par Value | 2025-02-12 | A | A | 252,000 | $0.00 | 252,000 | D | — | — |